ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,486,000 | +0.2% | 343,118 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $3,479,000 | -7.7% | 342,455 | -7.7% | 0.00% | 0.0% |
| Q3 2021 | $3,770,000 | -21.9% | 371,035 | -21.9% | 0.00% | 0.0% |
| Q2 2021 | $4,827,000 | +14.2% | 475,069 | +10.9% | 0.00% | 0.0% |
| Q1 2021 | $4,225,000 | -1.9% | 428,495 | +7.9% | 0.00% | 0.0% |
| Q4 2020 | $4,306,000 | +5.6% | 397,228 | +0.3% | 0.00% | -50.0% |
| Q3 2020 | $4,079,000 | -45.1% | 396,011 | +11.3% | 0.00% | -33.3% |
| Q2 2020 | $7,426,000 | +207.4% | 355,681 | +43.8% | 0.00% | +200.0% |
| Q1 2020 | $2,416,000 | -2.6% | 247,280 | +14.8% | 0.00% | 0.0% |
| Q4 2019 | $2,480,000 | +115.5% | 215,312 | +2.0% | 0.00% | – |
| Q3 2019 | $1,151,000 | -55.0% | 211,153 | -1.9% | 0.00% | -100.0% |
| Q2 2019 | $2,559,000 | – | 215,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,102,735 | $3,485,000 | 3.61% |
| VHCP Management II, LLC | 280,000 | $885,000 | 0.53% |
| GREAT POINT PARTNERS LLC | 550,116 | $1,738,000 | 0.50% |
| JW Asset Management, LLC | 189,919 | $600,000 | 0.48% |
| DAFNA Capital Management LLC | 140,600 | $444,000 | 0.35% |
| Granite Point Capital Management, L.P. | 186,544 | $589,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 779,926 | $2,465,000 | 0.13% |
| TFS CAPITAL LLC | 159,364 | $504,000 | 0.09% |
| Rhenman & Partners Asset Management AB | 154,006 | $487,000 | 0.09% |
| Numeric Investors LLC | 1,134,931 | $3,586,000 | 0.03% |